“Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease I Wilcox, SG McNamara, FL Collins, RR Grunstein, CE Sullivan Thorax 53 (suppl 3), S25-S28, 1998 | 459 | 1998 |
0029 BDNF VAL66MET POLYMORPHISM IMPACTS ALERTNESS AND PERFORMANCE IN SHIFT WORKERS AC Burns, TL Sletten, M Magee, Z Hawi, CL Nicholas, R Saxena, S Ftouni, ... Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A11-A11, 2017 | | 2017 |
0319 FAMILY physician management of insomnia in Australia: The beach study (2000–15) CB Miller, L Valenti, C Harrison, DJ Bartlett, N Glozier, NE Cross, ... Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A118-A118, 2017 | 1 | 2017 |
0346 Cannabinol (CBN) effects in insomnia disorder: A randomised, double-blind, placebo-controlled, crossover, clinical trial protocol I Lavender, I McGregor, A Sureav, D McCartney, C Irwin, N Marshall, ... Sleep 46 (Supplement_1), A153-A154, 2023 | 1 | 2023 |
0441 Sleep Disturbance in MCI: A Pilot Study of a Cognitive Behavioural Therapy Digital Intervention (SUCCEED) C Hoyos, N Espinosa, N Marshall, H LaMonica, C Gordon, ... Sleep 47 (Supplement_1), A189-A189, 2024 | | 2024 |
0452 Intra-individual Stability of Quantitative EEG as a Biomarker in Obstructive Sleep Apnea J Chapman, J Poon, KK Wong, AE Mullins, G Cho, BJ Yee, J Kim, ... Sleep 41, A171, 2018 | | 2018 |
0456 Comparative Safety and Efficacy of Hypnotics: A Quantitative Risk-Benefit Analysis J Cheung, H Scott, A Muench, K Morales, R Grunstein, A Krystal, ... Sleep 45 (Supplement_1), A202-A202, 2022 | 1 | 2022 |
0514 SIX MONTHS OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT IMPROVES NEUROBEHAVIORAL FUNCTION AND QUANTITATIVE SLEEP ELECTROENCEPHALOGRAM MEASURES IN OBSTRUCTIVE SLEEP APNEA AL D’Rozario, C Hoyos, J Kim, A Vakulin, KK Wong, J Leow, DJ Bartlett, ... Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A191-A192, 2017 | | 2017 |
0557 THE ROLE OF NIGHTLY ZOPICLONE ON OBSTRUCTIVE SLEEP APNEA SEVERITY AND SYMPTOMS IN PEOPLE WITH LOW TO MODERATE RESPIRATORY AROUSAL THRESHOLDS: A RANDOMIZED, DOUBLE-BLIND … SG Carter, JC Carberry, G Cho, LP Fisher, CP Rollo, D Stevens, ... Sleep 40, A207, 2017 | 1 | 2017 |
0567 Tirzepatide for the treatment of OSA: rationale and design of the SURMOUNT-OSA phase 3 trial A Malhotra, J Bednarik, A Curtis, J Dunn, T Weaver, R Grunstein, I Fietze, ... Sleep 46 (Supplement_1), A249-A250, 2023 | 3 | 2023 |
0572 DIET, EXERCISE AND ARMODAFINIL FOR OBSTRUCTIVE SLEEP APNEA (OSA) PATIENTS UNABLE TO TOLERATE STANDARD TREATMENTS (DEAR): A RANDOMIZED, PARALLEL-GROUP, FACTORIAL TRIAL JL Chapman, EA Cayanan, CM Hoyos, Y Serinel, BJ Yee, KK Wong, ... Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A212-A213, 2017 | | 2017 |
0614 IS OBSTRUCTIVE SLEEP APNEA RELATED TO NEUROPSYCHOLOGICAL FUNCTION IN HEALTHY OLDER ADULTS? A SYSTEMATIC REVIEW AND META-ANALYSIS N Cross, A Lampit, J Pye, R Grunstein, N Marshall, S Naismith Sleep 40, A227-A228, 2017 | | 2017 |
0620 Effect of Tirzepatide on Weight Loss in Patients with Obstructive Sleep Apnea and Obesity from SURMOUNT-1 RR Grunstein, R Taylor, S Shinde, JP Dunn, J Bednarik, A Stefanski, ... Sleep 47 (Supplement_1), A264-A265, 2024 | | 2024 |
0669 The Effects Of Continuous Positive Airway Pressure Therapy In Moderate To Severe Obstructive Sleep Apnea: A High-density EEG Study AL D’Rozario, C Kao, AE Mullins, N Memarian, B Yee, S Duffy, ... Sleep 43 (Supplement_1), A255-A255, 2020 | | 2020 |
0672 The Effect Of Armodafinil On Sleep Spindles In Obstructive Sleep Apnea: Secondary Analysis Of A Randomized Placebo-controlled Trial L Emami, NS Marshall, JL Chapman, G Cho, RR Grunstein, BJ Yee, ... Sleep 43 (Supplement_1), A256-A257, 2020 | | 2020 |
0848 CLINICAL, POLYSOMNOGRAPHIC AND NEUROPHYSIOLOGICAL CORRELATES OF SLEEP-DEPENDENT MEMORY WITH AGING AL D’Rozario, L Grummitt, NE Cross, DJ Bartlett, RR Grunstein, ... Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A314-A314, 2017 | | 2017 |
103 Biology and pathophysiology of disease: Lessons learned using positive pressure (effect of CPAP on glycemic control, CVD, dementia learning in kids) R Grunstein Sleep Medicine, S2, 2006 | | 2006 |
1127 Utility of Quantitative EEG During Sleep as a Potential Biomarker of Lewy Body Disease Progression E Matar, KA Ehgoetz Martens, RR Grunstein, A D’Rozario, SJ Lewis Sleep 43 (Supplement_1), A429-A429, 2020 | | 2020 |
1158 REDUCED SLEEP SPINDLE ACTIVITY IN PARKINSON’S DISEASE IS ASSOCIATED WITH NEUROPSYCHOLOGICAL IMPAIRMENT AE Mullins, SJ Bolitho, Z Terpening, AL D’Rozario, JW Kim, KL Melehan, ... Sleep 40, A432, 2017 | 1 | 2017 |
145 Metabolic risk management in OSA–Are we doing enough? R Grunstein Sleep Medicine, S19, 2006 | | 2006 |